FI52344B - - Google Patents

Info

Publication number
FI52344B
FI52344B FI2928/68A FI292868A FI52344B FI 52344 B FI52344 B FI 52344B FI 2928/68 A FI2928/68 A FI 2928/68A FI 292868 A FI292868 A FI 292868A FI 52344 B FI52344 B FI 52344B
Authority
FI
Finland
Application number
FI2928/68A
Other languages
Finnish (fi)
Other versions
FI52344C (fi
Inventor
Kevan Brown
John Frederick Cavalla
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of FI52344B publication Critical patent/FI52344B/fi
Application granted granted Critical
Publication of FI52344C publication Critical patent/FI52344C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI682928A 1967-10-26 1968-10-16 Menetelmä farmaseuttisesti vaikuttavien oksatsolien ja tiatsolien valm istamiseksi. FI52344C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB48641/67A GB1245087A (en) 1967-10-26 1967-10-26 Heterocyclic compounds

Publications (2)

Publication Number Publication Date
FI52344B true FI52344B (it) 1977-05-02
FI52344C FI52344C (fi) 1977-08-10

Family

ID=10449374

Family Applications (1)

Application Number Title Priority Date Filing Date
FI682928A FI52344C (fi) 1967-10-26 1968-10-16 Menetelmä farmaseuttisesti vaikuttavien oksatsolien ja tiatsolien valm istamiseksi.

Country Status (16)

Country Link
US (1) US3579529A (it)
JP (1) JPS4939262B1 (it)
BE (1) BE722458A (it)
BR (1) BR6803478D0 (it)
CH (2) CH596194A5 (it)
DE (1) DE1804306A1 (it)
ES (1) ES359528A1 (it)
FI (1) FI52344C (it)
FR (2) FR1597568A (it)
GB (1) GB1245087A (it)
IE (1) IE32399B1 (it)
IL (1) IL30789A0 (it)
IT (1) IT1061738B (it)
LU (1) LU57134A1 (it)
NL (1) NL6815221A (it)
SE (1) SE384860B (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2068396A1 (en) * 1969-10-02 1971-08-27 Squibb & Sons Inc adamantyl thiadiazoles. antifungals
IE52909B1 (en) * 1981-04-28 1988-04-13 Wyeth John & Brother Ltd Oxazole derivatives
JPS57188587A (en) * 1981-05-15 1982-11-19 Tanabe Seiyaku Co Ltd Thienyloxazolylacetic acid derivative and its preparation
JPS58148882A (ja) * 1982-02-26 1983-09-05 Tanabe Seiyaku Co Ltd フリルオキサゾリル酢酸誘導体及びその製法
JPS58183676A (ja) * 1982-04-19 1983-10-26 Takeda Chem Ind Ltd オキサゾ−ル誘導体
JPS58219169A (ja) * 1982-06-15 1983-12-20 Takeda Chem Ind Ltd オキサゾ−ル酢酸誘導体
FR2596760B1 (fr) * 1986-04-02 1988-12-09 Sori Soc Rech Ind Derives dissymetriques de l'acide 1,4-dihydropyridine-3,5-dicarboxylique, procedes de preparation et utilisation en therapeutique
ES2144403T3 (es) * 1990-11-30 2000-06-16 Otsuka Pharma Co Ltd Derivados de tiazol como inhibidores de oxigeno activo.
FR2699172B1 (fr) * 1992-12-11 1995-01-20 Adir Nouveaux dérivés de 4-méthyl-1,3-oxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
MY128323A (en) * 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion
AU2002246397B2 (en) * 2001-04-16 2005-03-24 Tanabe Seiyaku Co., Ltd. Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence

Also Published As

Publication number Publication date
LU57134A1 (it) 1969-01-31
IE32399L (en) 1969-04-26
DE1804306A1 (de) 1969-05-22
SE384860B (sv) 1976-05-24
BR6803478D0 (pt) 1973-02-22
IE32399B1 (en) 1973-07-25
US3579529A (en) 1971-05-18
IT1061738B (it) 1983-04-30
BE722458A (it) 1969-04-17
CH536313A (de) 1973-04-30
GB1245087A (en) 1971-09-02
FR1597568A (it) 1970-06-29
NL6815221A (it) 1969-04-29
FI52344C (fi) 1977-08-10
IL30789A0 (en) 1968-11-27
ES359528A1 (es) 1970-06-01
FR7986M (it) 1970-06-08
JPS4939262B1 (it) 1974-10-24
CH596194A5 (it) 1978-03-15

Similar Documents

Publication Publication Date Title
AU425114B2 (it)
AT298283B (it)
FI52344B (it)
DK137674C (it)
AU2277767A (it)
AU1273466A (it)
AU2454867A (it)
AU2256867A (it)
AU2116667A (it)
BE692780A (it)
BE692493A (it)
AU1868267A (it)
AU1677166A (it)
AU1614766A (it)
BE710510A (it)
BE710057A (it)
BE709805A (it)
BE709080A (it)
BE692779A (it)
BE692778A (it)
BE692654A (it)
BE692577A (it)
BE692553A (it)
BE614676A (it)
AU1763766A (it)